Cardinal Health has good read through from AmerisourceBergen, says Sterne Agee Sterne Agee believes that AmericansourceBergen's (ABC) beat and raise results bode well for Cardinal Health (CAH). The firm keeps a Buy rating on Cardinal.
AmerisourceBergen now sees FY14 adjusted continuing ops EPS $3.89-$3.94 Consensus is $3.73. Sees FY14 revenue growth in the 35% range, consensus $116.72B. The company says "Adjusted operating margin is expected to decline in the high-teens basis points range due to the onboarding of significant new lower margin business and growth in brand pharmaceutical business with our large customers. We expect free cash flow to be in the high end of the range of $500 to $700 million, with capital expenditures in the $275 million range, and to spend approximately $500 million in share repurchases, subject to market conditions."